Table 1 Patient baseline characteristics
From: The epidemiology of herpes zoster and its complications in Medicare cancer patients
Hematologic cancer patients1 | Solid cancer patients2 | Non-cancer patients | P-value hematologic cancer vs. non-cancer | P-value solid cancer vs. non-cancer | |
|---|---|---|---|---|---|
Age at index date, mean ± SD3 | 77.5 ± 7.3 | 76.1 ± 6.9 | 74.7 ± 7.2 | <0.0001 | <0.0001 |
Gender, n (%) | |||||
Male | 40,516 (49.0%) | 516,011 (55.1%) | 91,940 (37.3%) | <0.0001 | <0.0001 |
Female | 42,232 (51.0%) | 419,916 (44.9%) | 154,368 (62.7%) | <0.0001 | <0.0001 |
Race, n (%) | |||||
White | 73,895 (89.3%) | 808,178 (86.4%) | 207,161 (84.1%) | <0.0001 | <0.0001 |
Black | 3,923 (4.7%) | 74,168 (7.9%) | 18,760 (7.6%) | <0.0001 | <0.0001 |
Asian/Pacific Islander | 1,800 (2.2%) | 21,116 (2.3%) | 7,811 (3.2%) | <0.0001 | <0.0001 |
Hispanic | 1,203 (1.5%) | 12,237 (1.3%) | 5,896 (2.4%) | <0.0001 | <0.0001 |
North American Native/Alaska Native | 155 (0.2%) | 1,952 (0.2%) | 901 (0.4%) | <0.0001 | <0.0001 |
Other | 1,489 (1.8%) | 15,674 (1.7%) | 5,013 (2.0%) | <0.0001 | <0.0001 |
Months before the index date, mean ± SD3 | 110.9 ± 64.8 | 101.4 ± 62.4 | 85.6 ± 47.6 | <0.0001 | <0.0001 |
Months after the index date, mean ± SD3 | 37.8 ± 41.3 | 52.1 ± 48.8 | 85.3 ± 62.6 | <0.0001 | <0.0001 |
Charlson Comorbidity Index, mean ± SD3 | 0.7 ± 1.1 | 0.7 ± 1.1 | 0.5 ± 0.9 | <0.0001 | <0.0001 |